Assay for Melatonin Receptor-Binding Affinity and Expression in Mitochondria.

YS Yalikun Suofu
WL Wei Li
FJ Frédéric G. Jean-Alphonse
JJ Jiaoying Jia
NK Nicolas K. Khattar
JL Jiatong Li
SB Sergei V. Baranov
DL Daniela Leronni
AM Amanda C. Mihalik
YH Yanqing He
EC Erika Cecon
VW Vanessa L. Wehbi
JK JinHo Kim
BH Brianna E. Heath
OB Oxana V. Baranova
XW Xiaomin Wang
MG Matthew J. Gable
EK Eric S. Kretz
GB Giulietta Di Benedetto
TL Timothy R. Lezon
LF Lisa M. Ferrando
TL Timothy M. Larkin
MS Mara Sullivan
SY Svitlana Yablonska
JW Jingjing Wang
MM M. Beth Minnigh
GG Gérald Guillaumet
FS Franck Suzenet
RR R. Mark Richardson
SP Samuel M. Poloyac
DS Donna B. Stolz
RJ Ralf Jockers
PW Paula A. Witt-Enderby
DC Diane L. Carlisle
JV Jean-Pierre Vilardaga
RF Robert M. Friedlander
request Request a Protocol
ask Ask a question
Favorite

The affinity (Ki) of melatonin for melatonin receptors located in B6CBA wild-type mouse brain mitochondria (0.06–0.09 mg protein per tube) and PM (0.24–0.26 mg protein per tube) was assessed by competition binding analysis using 100 pM 2-[125I]-iodomelatonin and 1 pM–100 nM melatonin as described (46). Total melatonin receptor expression (Bmax) and affinity (Kd) of 2-[125I]-iodomelatonin binding to melatonin receptors were assessed in mitochondria (0.06–0.22 mg protein per tube) and whole-brain homogenates (0.25–0.46 mg protein per tube) by saturation isotherms using 0–500 pM 2-[125I]-iodomelatonin for PM and 0–2.4 nM for mitochondria. Nonspecific binding was determined using 10 μM melatonin. Parallel binding assays were performed in the presence of 1 mM DTT using 250–500 pM 2-[II25]-iodomelatonin. Data were best-fit analyzed by nonlinear regression analysis least-squares fit (GraphPad Prism, Inc.) (SI Appendix, Fig. S4).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A